Basic Information
AVEROA is a biopharmaceutical company founded in December 2021, bringing innovative therapeutic solutions to patients with kidney diseases. AVEROA's goal is to build, advance, and commercialize a robust product pipeline to address significant unmet medical needs of patients with kidney or metabolic disorders.